收藏切换
Research progress of small molecular drugs targeting RNA
收藏切换
PDF
Xiao-li DU, Hui-hui CHEN, Xiang-yang YE*, Tian XIE*, Xing-rui HE*
Acta Pharmaceutica Sinica | 2022, 57(10) : 2902 - 2913
Less
收藏切换
Acta Pharmaceutica Sinica | 2022, 57(10): 2902-2913
Special Reports Ⅰ: New Targets, New Strategies for Drug Discovery and Advances in Antiviral Drug Research
Research progress of small molecular drugs targeting RNA
Full
Xiao-li DU, Hui-hui CHEN, Xiang-yang YE*, Tian XIE*, Xing-rui HE*
Affiliations
  • Key Laboratory of Elemene Class Anti-Cancer Chinese Medicines; Engineering Laboratory of Development and Application of Traditional Chinese Medicines; Collaborative Innovation Center of Traditional Chinese Medicines of Zhejiang Province, School of Pharmacy, Hangzhou Normal University, Hangzhou 311121, China
Published: 2022-10-12 doi: 10.16438/j.0513-4870.2022-0430
Outline
收藏切换

At present, majority of the small molecular drugs used in clinics target proteins, they exert the efficacy through the binding to specific sites on the target protein. However, the "druggable" protein targets account for a small portion of the total number of proteins, and "non-druggable" proteins account for 80%, because of not having suitable drug binding sites. In the central rule, RNA is located in the upstream of proteins and controls the transcription of proteins. The research of small molecule drugs targeting RNA can solve the problem of protein "undruggable proteins" in some extent. This review summarizes the representative research achievements of small molecular drugs targeting RNA in recent years, and the screening methods applied to this field, with the focuses on the latest progress of small molecular drugs targeting novel coronavirus RNA.

RNA  /  small molecular drug  /  targeted RNA small molecular drug  /  screening method  /  novel coronavirus
Xiao-li DU, Hui-hui CHEN, Xiang-yang YE, Tian XIE, Xing-rui HE. Research progress of small molecular drugs targeting RNA[J]. Acta Pharmaceutica Sinica, 2022 , 57 (10) : 2902 -2913 . DOI: 10.16438/j.0513-4870.2022-0430
Year 2022 volume 57 Issue 10
PDF
195
80
Cite this Article
BibTeX
Article Info
doi: 10.16438/j.0513-4870.2022-0430
  • Receive Date:2022-04-13
  • Online Date:2025-12-24
  • Published:2022-10-12
Article Data
Affiliations
History
  • Received:2022-04-13
  • Revised:2022-05-26
Funding
Affiliations
    Key Laboratory of Elemene Class Anti-Cancer Chinese Medicines; Engineering Laboratory of Development and Application of Traditional Chinese Medicines; Collaborative Innovation Center of Traditional Chinese Medicines of Zhejiang Province, School of Pharmacy, Hangzhou Normal University, Hangzhou 311121, China
References
Share
https://castjournals.cast.org.cn/joweb/yxxb/EN/10.16438/j.0513-4870.2022-0430
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数

Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)

Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT